ISRCTN64826232Completed未知
Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through vitamin K: a single centre randomised controlled trial
ewcastle upon Tyne Hospitals NHS Foundation Trust (UK)0 sites180 target enrollmentStarted: October 21, 2010Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 180
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Long term warfarin therapy
- •2. Aged greater than or equal to 18 years
- •3. Male and female
Exclusion Criteria
- •1. Abnormal hepatic or renal function
- •2. Impairment of cognitive function
Investigators
Similar Trials
Active, not recruiting
Phase 1
Improving the safety and efficacy of anticoagulation therapy for thromboembolic disease through vitamin K - Improving stability of anticoagulation through vitamin KPatients will be recruited who are receiving long term warfarin therapy for the treatment or prevention of venous or arterial thrombosis or embolismEUCTR2008-006238-87-GBewcastle upon Tyne Hospitals NHS Foundation Trust180
Not yet recruiting
Not Applicable
The efficacy and safety of anticoagulant therapy Arixtra Injection for the prevention of the vein thromboembolism in laparoscopic colorectal surgerycolorectal cancerJPRN-UMIN000007005Osaka Medical College200
Completed
Not Applicable
Efficacy and safety of anticoagulant treatment using new alternative antithrombotic agents in acute cardioembolic stroke with nonvalvular atrial fibrillation.cerebral infarctionJPRN-UMIN000010477Department of Neurology, Kansai Medical University50
Recruiting
Not Applicable
Efficacy and safety of anticoagulant treatment using New oral anticoagulant (edoxaban) in atrial fibrillation after cardiac surgery.arterial fibrillation after cardiac surgery (nonvalvular disease)JPRN-UMIN000021138ihon University school of medicine150
Completed
Not Applicable
A Study of Safety and efficacy of anticoagulant therapy in the treatment of Atrial Fibrillation in KANAGAWAAtrial fibrillationJPRN-UMIN000011830ASSAF-K steering committee5,000